Jalra-DP Tablet SR
Marketer
USV Ltd
Salt Composition
Dapagliflozin (10mg) + Vildagliptin (100mg)
Overview Jalra-DP Tablet SR
Metformin-glimepiride extended-release tablets manage blood glucose in adults with type 2 diabetes. This medication complements diet and exercise to enhance blood sugar regulation by improving insulin effectiveness and reducing glucose levels. The tablets can be ingested with or without food, consistently at the same time daily, as directed by your physician. Discontinuing use without consulting your doctor can lead to elevated blood sugar, potentially causing severe complications such as kidney disease and vision loss. This medication is part of a comprehensive treatment plan involving a healthy diet, regular physical activity, and weight management under your doctor's guidance. Potential side effects include low blood sugar (hypoglycemia), vaginal infections, urinary tract infections, lightheadedness, trembling, and headaches. Adequate hydration helps mitigate dehydration. Genital fungal infections are possible; proper hygiene is crucial for prevention. Prior to starting this medication, disclose any kidney or liver issues, urinary tract infections, or diuretic use to your doctor. Pregnant or nursing women should seek medical advice before use. Excessive alcohol consumption should be avoided due to increased risk of side effects. Regular blood glucose monitoring is essential during treatment.
Uses of Jalra-DP Tablet SR
Managing type 2 diabetes
Major Benefits of Jalra-DP Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Jalra-DP Tablet SR can be administered with or without food, though consistent timing is recommended.
Common Side effects of Jalra-DP Tablet SR:
- Headache
- Vaginal inflammation
- Balanitis
- Urinary tract infection
- Hypoglycemia (low blood glucose level)
- Dizziness
- Tremors
- Fatigue
- Nausea
- Rash
- Back pain
- Polyuria
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Jalra-DP Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jalra-DP Tablet SR can be administered with or without food, however, consistent timing is recommended.
How Jalra-DP Tablet SR works:
Jalra-DP SR tablets combine two antidiabetic agents. Dapagliflozin works by enhancing glucose elimination through the kidneys, thereby lowering blood sugar. Vildagliptin acts to decrease hepatic glucose production; this occurs via augmented insulin secretion and suppressed glucagon levels, thus counteracting the hyperglycemic effects of glucagon.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Jalra-DP Tablet SR may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Data on Jalra-DP Tablet SR use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Jalra-DP Tablet SR use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Jalra-DP Tablet SR on driving ability is undetermined. Refrain from driving if you experience any symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Jalra-DP Tablet SR use in individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Jalra-DP Tablet SR use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Jalra-DP Tablet SR :
Should you forget a dose of Jalra-DP Tablet SR, take it promptly. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Jalra-DP Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |




